Literature DB >> 28345140

Global trends in the burden of liver cancer.

Chandrakanth Are1, Bria Meyer1, Apollo Stack2, Humera Ahmad3, Lynette Smith4, Biyun Qian5, Tianqiang Song6, Sanjib Chowdhury7.   

Abstract

BACKGROUND: The aim of this study is to describe the influence of geography, socio-economic development, and demographic shift on the trends in global incidence, mortality, and prevalence of liver cancer (LC).
METHODS: Data (2012-2030) relating to LC and demographic shifts based on WHO regions and HDI areas were extracted from GLOBOCAN 2012 and analyzed to evaluate trends in incidence, mortality, and prevalence.
RESULTS: The results of our study document a rising global burden of LC with the maximum impact in the WPRO region. We did not observe a definite association between LC and higher socio-economic status with the highest burden in the MHD region. For the MHD region, we noticed age reversal in burden from the younger age group currently to the older age group in the future (2030). Another finding is the high burden and early onset of disease in some low-income countries such as Mongolia, Lao PDR, and Vietnam.
CONCLUSION: The results of our study demonstrate a rising global burden of LC with some significant but uneven trends based on geography, age, and socio-economic status. This information can be used to shape policy and aid strategic targeting of resources to areas with the highest burden.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Human Development Index; WHO regions; burden; demographic shift; liver cancer

Mesh:

Year:  2017        PMID: 28345140     DOI: 10.1002/jso.24518

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  14 in total

1.  Expansion of Liver Transplantation Criteria for Hepatocellular Carcinoma from Milan to UCSF in Australia and New Zealand and Justification for Metroticket 2.0.

Authors:  Savio G Barreto; Simone I Strasser; Geoffrey W McCaughan; Michael A Fink; Robert Jones; John McCall; Stephen Munn; Graeme A Macdonald; Peter Hodgkinson; Gary P Jeffrey; Bryon Jaques; Michael Crawford; Mark E Brooke-Smith; John W Chen
Journal:  Cancers (Basel)       Date:  2022-06-03       Impact factor: 6.575

2.  Global Mortality Burden of Cirrhosis and Liver Cancer Attributable to Injection Drug Use, 1990-2016: An Age-Period-Cohort and Spatial Autocorrelation Analysis.

Authors:  Jin Yang; Yunquan Zhang; Lisha Luo; Runtang Meng; Chuanhua Yu
Journal:  Int J Environ Res Public Health       Date:  2018-01-22       Impact factor: 3.390

3.  Cost of illness of hepatocellular carcinoma in Japan: A time trend and future projections.

Authors:  Kunichika Matsumoto; Yinghui Wu; Takefumi Kitazawa; Shigeru Fujita; Kanako Seto; Tomonori Hasegawa
Journal:  PLoS One       Date:  2018-06-19       Impact factor: 3.240

4.  SERPINA3 is a key modulator of HNRNP-K transcriptional activity against oxidative stress in HCC.

Authors:  Eunkyong Ko; Jong-Seo Kim; Jong Woo Bae; Jeesoo Kim; Sung-Gyoo Park; Guhung Jung
Journal:  Redox Biol       Date:  2019-05-12       Impact factor: 11.799

5.  Comparison of the cost of illness of primary liver cancer between Japan and Taiwan.

Authors:  Yinghui Wu; Kunichika Matsumoto; Ya-Mei Chen; Yu-Chi Tung; Tzu-Ying Chiu; Tomonori Hasegawa
Journal:  Health Econ Rev       Date:  2020-12-05

6.  Liver Cancer Survival: A Real World Observation of 45 Years with 32,556 Cases.

Authors:  Jian-Guo Chen; Jian Zhu; Yong-Hui Zhang; Yong-Sheng Chen; Lu-Lu Ding; Hai-Zhen Chen; Ai-Guo Shen; Gao-Ren Wang
Journal:  J Hepatocell Carcinoma       Date:  2021-08-31

7.  Mortality Associated with Hepatobiliary Disease in Portugal between 2006 and 2012.

Authors:  Manuel Coelho da Rocha; Rui T Marinho; Teresa Rodrigues
Journal:  GE Port J Gastroenterol       Date:  2017-12-06

8.  A quantitative proteomic response of hepatocellular carcinoma Hep3B cells to danusertib, a pan-Aurora kinase inhibitor.

Authors:  Qiaohua Zhu; Xinfa Yu; Zhi-Wei Zhou; Meihua Luo; Chengyu Zhou; Zhi-Xu He; Yong Chen; Shu-Feng Zhou
Journal:  J Cancer       Date:  2018-05-24       Impact factor: 4.207

9.  Low expression of citron kinase is associated with poor patient outcomes in hepatocellular carcinoma.

Authors:  Huan-Qing Zhang; Hui-Ju Wang; Xiang-Lei He; Guo-Qing Ru; Shu-Shu Song; Hong-Ying Pan; Cheng-Wu Zhang; Xiao-Zhou Mou; Zhi-Ming Hu
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

10.  A scoring model combining serum alpha-fetoprotein and tumor size and number predicts prognosis in hepatitis B virus-related hepatocellular carcinoma patients after curative hepatectomy.

Authors:  Bai Wei; Jing-San Chen; Sheng-Li Yang; George G Chen; Hao He
Journal:  Transl Cancer Res       Date:  2019-08       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.